ATOS (Atossa Therapeutics) Short-term investments


ATOS Atossa Therapeutics Inc ATOS
26 GF Score
Price $2.37
! 2 Warning Signs
View Full Analysis

What is Atossa Therapeutics Short-term investments?

Short-term investments only applies to insurance companies.

ATOS
26GF Score
Atossa Therapeutics Inc ATOS
Short-term investments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Atossa Therapeutics Business Description

Other Exchanges ATOS:MexicoYAG:Germany
Address 1448 NW Market Street, Suite 500, Seattle, WA, USA, 98107
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.
26GF Score

Get the complete analysis for ATOS

Short-term investments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.37
Price